XML 42 R29.htm IDEA: XBRL DOCUMENT v3.19.1
Business Segment and Geographical Information (Tables)
 3 Months Ended
Mar. 30, 2019
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Business Segment Information
 
 
Three Months Ended
 
 
March 30,

 
March 31,

(In millions)
 
2019

 
2018

 
 
 
 
 
Revenues
 
 
 
 
Life Sciences Solutions
 
$
1,607

 
$
1,499

Analytical Instruments
 
1,322

 
1,257

Specialty Diagnostics
 
957

 
947

Laboratory Products and Services
 
2,513

 
2,413

Eliminations
 
(274
)
 
(263
)
 
 
 
 
 
Consolidated revenues
 
6,125

 
5,853

 
 
 
 
 
Segment Income (a)
 
 
 
 
Life Sciences Solutions
 
561

 
517

Analytical Instruments
 
282

 
246

Specialty Diagnostics
 
242

 
243

Laboratory Products and Services
 
285

 
280

 
 
 
 
 
Subtotal reportable segments (a)
 
1,370

 
1,286

 
 
 
 
 
Cost of revenues charges, net
 
(6
)
 
(3
)
Selling, general and administrative charges, net
 
(11
)
 
(8
)
Restructuring and other costs, net
 
(11
)
 
(45
)
Amortization of acquisition-related intangible assets
 
(422
)
 
(444
)
 
 
 
 
 
Consolidated operating income
 
920

 
786

Other expense, net (b)
 
(103
)
 
(152
)
 
 
 
 
 
Income from continuing operations before income taxes
 
$
817

 
$
634

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Business Segment Information
 
 
Three Months Ended
 
 
March 30,

 
March 31,

(In millions)
 
2019

 
2018

 
 
 
 
 
Revenues
 
 
 
 
Life Sciences Solutions
 
$
1,607

 
$
1,499

Analytical Instruments
 
1,322

 
1,257

Specialty Diagnostics
 
957

 
947

Laboratory Products and Services
 
2,513

 
2,413

Eliminations
 
(274
)
 
(263
)
 
 
 
 
 
Consolidated revenues
 
6,125

 
5,853

 
 
 
 
 
Segment Income (a)
 
 
 
 
Life Sciences Solutions
 
561

 
517

Analytical Instruments
 
282

 
246

Specialty Diagnostics
 
242

 
243

Laboratory Products and Services
 
285

 
280

 
 
 
 
 
Subtotal reportable segments (a)
 
1,370

 
1,286

 
 
 
 
 
Cost of revenues charges, net
 
(6
)
 
(3
)
Selling, general and administrative charges, net
 
(11
)
 
(8
)
Restructuring and other costs, net
 
(11
)
 
(45
)
Amortization of acquisition-related intangible assets
 
(422
)
 
(444
)
 
 
 
 
 
Consolidated operating income
 
920

 
786

Other expense, net (b)
 
(103
)
 
(152
)
 
 
 
 
 
Income from continuing operations before income taxes
 
$
817

 
$
634

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
Geographical Information
 
 
Three Months Ended
 
 
March 30,

 
March 31,

(In millions)
 
2019

 
2018

 
 
 
 
 
Revenues (c)
 
 
 
 
United States
 
$
2,918

 
$
2,756

China
 
654

 
541

Other
 
2,553

 
2,556

 
 
 
 
 
Consolidated revenues
 
$
6,125

 
$
5,853

(c)
Revenues are attributed to countries based on customer location.